Welcome to CDC stacks | Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes - 42762 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
Filetype[PDF-964.03 KB]


Details:
No Related Documents.
You May Also Like:
  1. Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009–2013
    Personal Author:
    Cameron, Ross L.; Kavanagh, Kimberley; Pan, Jiafeng; Love, John; Cuschieri, Kate; Robertson, Chris; Ahmed, Syed; Palmer, Timothy; Pollock, Kevin G.J.;
    Published:
    Jan 2016
    Source:
    Emerg Infect Dis. 22(1):56-64.
    Description:
    In 2008, a national human papillomavirus (HPV) immunization program using a bivalent vaccine against HPV types 16 and 18 was implemented in Scotland along with a national surveillance program designed to determine the longitudinal effects of vaccinat...
    File Type:
    Filetype[PDF - 527.22 KB]
  2. Human papillomavirus vaccination : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Markowitz, Lauri E.; Dunne, Eileen F.; Saraiya, Mona; Chesson, Harrell W.; Curtis, C. Robinette; Gee, Julianne; Bocchini, Joseph A.; Unger, Elizabeth R., 1951-;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention..
    Published:
    August 29, 2014
    Source:
    MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 63, RR-05
    Description:
    This report summarizes the epidemiology of human papillomavirus (HPV) and associated diseases, describes the licensed HPV vaccines, provides updated data from clinical trials and postlicensure safety studies, and compiles recommendations from CDC's A...
    Status:
    current
    File Type:
    Filetype[PDF - 757.82 KB]
  3. Human papillomavirus vaccination : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Markowitz, Lauri E.; Dunne, Eileen F.; Saraiya, Mona; Chesson, Harrell W.; Curtis, C. Robinette; Gee, Julianne; Bocchini, Joseph A.; Unger, Elizabeth R., 1951-;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention..
    Published:
    August 29, 2014
    Source:
    MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 63, RR-05
    Description:
    This report summarizes the epidemiology of human papillomavirus (HPV) and associated diseases, describes the licensed HPV vaccines, provides updated data from clinical trials and postlicensure safety studies, and compiles recommendations from CDC's A...
    Status:
    current
    File Type:
    Filetype[PDF - 690.92 KB]
  4. Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
    Personal Author:
    Oliver, Sara E.; Unger, Elizabeth R.; Lewis, Rayleen; McDaniel, Darius; Gargano, Julia W.; Steinau, Martin; Markowitz, Lauri E.;
    Published:
    Sep 01 2017
    Source:
    J Infect Dis. 216(5):594-603.
    Description:
    Background : Human papillomavirus (HPV) vaccine was recommended in 2006 for routine vaccination of US females aged 11–12 years. Most vaccine used through 2014 was quadrivalent vaccine (4vHPV), which prevents HPV-6, -11, -16, and -18 infection. To e...
    File Type:
    Filetype[PDF - 506.86 KB]
  5. Coming Soon
    Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014
    Personal Author:
    McClung, Nancy M.; Gargano, Julia W.; Bennett, Nancy M.; Niccolai, Linda M.; Abdullah, Nasreen; Griffin, Marie R.; Park, Ina U.; Cleveland, Angela A.; Querec, Troy D.; Unger, Elizabeth R.; Markowitz, Lauri E.;
    Corporate Author:
    HPV-IMPACT Working Group
    Published:
    February 21 2019
    Source:
    Cancer Epidemiol Biomarkers Prev. 28(3):602-609
    Description:
    Background: : The impact of human papillomavirus (HPV) vaccination has been observed in the United States through declining cervical precancer incidence in young women. To further evaluate vaccine impact, we described trends in HPV vaccine types 16/1...
    Public Access
    Available on:
    March 01, 2020